In endometrial cancer, LPCAT1 affects the activation of the transforming growth factor (TGF)-β-Smad2/3 pathway, which may explain the effect of LPCAT1 on tumor processes in this cancer [92]. This evidence concerns the gene LPCAT1 and neoplasm.